Skip to main content

Year: 2026

Lakeland Fire + Safety Appoints Kevin Rae to Executive Vice President, EMEA Fire Sales

Veteran Operational Executive to Lead Expanded Role Scaling Fire Business Across Europe, the Middle East, and Africa HUNTSVILLE, Ala., April 13, 2026 (GLOBE NEWSWIRE) — Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced the promotion of Kevin Rae to Executive Vice President, Europe, the Middle East, and Africa (“EMEA”) Fire Sales, leading Lakeland’s Fire business across Europe, the Middle East, and Africa, with direct responsibility for the Company’s Eagle, Jolly, and LHD brands. Kevin Rae brings more than 20 years of leadership experience in personal protective equipment (PPE) and fire safety across the UK and EMEA. Since joining Lakeland in 2022,...

Continue reading

LM Funding America Announces March 2026 Production and Operational Update

Bitcoin treasury as of March 31, 2026 was 341.2 BTC valued at $22.9 million or $1.07 per share¹ TAMPA, Fla., April 13, 2026 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced its preliminary, unaudited Bitcoin mining and operational update for the month ended March 31, 2026.Metric February 2026 March 2026– Bitcoin2    – Mined, net 8.7 9.6– Sold 18.1 23.1– Purchased – –– Service Fee – –– Bitcoin HODL 354.73 341.23– Machines2    – Oklahoma 4,586 4,586– Mississippi 2,368 2,368– Storage 559 559– Total Machines 7,513 7,513– Hashrate (EH/s2)    – Oklahoma 0.55 0.56– Mississippi 0.23 0.23–...

Continue reading

Wrap Announces R&D Expansion into Net-Based Drone Interdiction, Advancing Non-Lethal Public Safety Capabilities

Company builds on Kevlar-based cassette platform to support drone-to-drone and air-to-ground non-lethal capture concepts for state, local, and federal public safety agencies MIAMI, April 13, 2026 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in Non-Lethal Response (“NLR”) and public safety technology, today announced a strategic research and development initiative focused on net-based drone capture technologies, expanding the Company’s NLR platform into aerial interdiction for public safety, law enforcement, critical infrastructure, and defense-adjacent applications. The initiative builds on Wrap’s Kevlar-based cassette technology, originally developed for the BolaWrap® platform, and extends that architecture into new aerial payload configurations designed to support the safe...

Continue reading

Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners

Policy Update Broadens Access to Innovative, Non-Drug Depression Treatment Across 26 States and Washington, D.C. MALVERN, Pa., April 13, 2026 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, announced that Optum/United Healthcare/United Behavioral Health (Optum/UHC/UBH) has updated its Transcranial Magnetic Stimulation (TMS) clinical policy to allow psychiatric mental health nurse practitioners (PMHNPs) to order, supervise, and administer TMS therapy. Previously, this authority was limited to psychiatrists. The updated policy applies to PMHNPs operating in states where full practice authority (FPA) is granted and...

Continue reading

Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury

Mackay Base Hospital activated March 31, 2026 as first clinical trial site; first patient dosed within days of activation — a signal of strong enrollment velocity and significant unmet medical needSARASOTA, Fla., April 13, 2026 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, today announced that the first patient has been dosed in its ongoing Phase IIa clinical trial evaluating ONP-002, the Company’s lead candidate for the treatment of concussion and mild traumatic brain injury (mTBI). The milestone was achieved at Mackay Hospital in Australia — the first site to be activated in the trial — within days of site activation on March 31, 2026. Concussion, aka, mild traumatic brain injury, represents...

Continue reading

MindBio Deploys New Technology Intox Collect™; Expands CNS Drug Detection Capabilities with Voice & Facial Recognition

New technology Intox Collect™ has been completed for collection and analysis of voice and facial recognition data using AI for alcohol and a range of new substances that effect the central nervous system.VANCOUVER, British Columbia, April 13, 2026 (GLOBE NEWSWIRE) — MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), (the “Company” or “MindBio”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has completed the development of new technology Intox Collect™ which has enabled the Company to rapidly scale its collection and analysis of data samples (including voice and facial recognition data) from a wide range of substances when consumed. Intox Collect™ is a novel software which has enhanced...

Continue reading

AtlasClear Holdings Files Regulatory Applications to Acquire Commercial Bancorp, Parent of Farmers State Bank

Filing Marks a Key Milestone in AtlasClear’s Strategy to Build a Vertically Integrated Financial Services PlatformFiling Marks a Key Milestone in AtlasClear’s Strategy to Build a Vertically Integrated Financial Services PlatformTAMPA, Fla., April 13, 2026 (GLOBE NEWSWIRE) — AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear” or the “Company”), a technology-enabled financial services holding company, today announced that it has submitted regulatory applications seeking approval to acquire Commercial Bancorp, a Bank Holding Company and the parent company of Farmers State Bank, a profitable, well-capitalized Federal Reserve member bank. The applications were filed with the Federal Reserve Board and the Wyoming Division of Banking, and represent the next step in the transaction process following the Company’s...

Continue reading

VisionWave Acquires xClibre™ AI Video Intelligence IP Assets

Adds visual perception layer to complement RF sensing across defense platforms WEST HOLLYWOOD, Calif., April 13, 2026 (GLOBE NEWSWIRE) — VisionWave Holdings, Inc. (Nasdaq: VWAV), a defense and advanced sensing technology company, today announced the completed acquisition of the intellectual property assets underlying the xClibre™ AI video intelligence platform, pursuant to a definitive Asset Purchase Agreement dated April 10, 2026. The acquired IP was independently valued at approximately $60 million, by BDO Consulting Group as of April 10, 2026. The acquisition is intended to fill a critical capability gap in VisionWave’s sensing architecture: until now, the Company’s platforms relied primarily on RF-based detection. xClibre add a visual perception layer that is expected to complement the Company’s existing RF-based detection...

Continue reading

Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Portage, Michigan, April 13, 2026 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK), a global leader in medical technologies, announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat calcified peripheral arterial disease. The acquisition will strengthen Stryker’s Peripheral Vascular (PV) portfolio by adding revascularization technology. Once cleared for use in applicable markets, the product will complement Stryker’s existing PV offerings and support the company’s strategy to expand its presence in arterial disease treatment. “This acquisition represents an important step in advancing our vision to build a comprehensive peripheral vascular platform and address significant...

Continue reading

Pacific Office Automation Acquires MKCNext, Establishing National Leadership in Wide-Format Technology

The move expands specialized wide-format capabilities in both sales and service nationwide, continuing a period of deliberate, strategic growth PORTLAND, Ore., April 13, 2026 (GLOBE NEWSWIRE) — Pacific Office Automation (POA), the largest independent office equipment reseller and managed services provider in the nation, today announced the acquisition of MKCNext, a Southern California-based leader in high-end wide-format printing equipment, service, and consumables. The transaction closed on April 1, 2026. Headquartered in Agoura Hills, California, MKCNext has built a nationally recognized reputation as a specialist in industrial wide-format technology, primarily Canon high-end wide-format equipment. The company offers comprehensive end-to-end solutions, including equipment sales, inks and media, color management and workflow optimization,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.